PerkinElmer | 15-Jul-2021
| Technical / White Paper
At Novartis, TIBCO Spotfire® enterprise analytics is a key tool for interactive graphical data analysis for preclinical and clinical studies. Using interactive...
PerkinElmer | 14-Jul-2021
| Technical / White Paper
Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...
With larger, more complex clinical trials, along with more stringent regulatory requirements and oversight, integrating and managing vast amounts of data...
The Piramal Pharma Solutions site in Grangemouth, UK offers development, clinical & commercial scale manufacture of bio-conjugates including Antibody...
The Piramal Pharma Solutions facility in Aurora Canada offers development, clinical and commercial GMP manufacturing of Active Pharmaceutical Ingredients...
PerkinElmer | 10-Jun-2021
| Technical / White Paper
Clinical development teams are under enormous pressure to navigate the lengthy and challenging clinical trial process, often needing to alchemize these...
PerkinElmer | 10-Jun-2021
| Technical / White Paper
Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...
This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...
Piramal Pharma Solutions | 08-Jun-2021
| Technical / White Paper
Facing capacity constraints? Lock in your program now! With 14 sites around the world providing diverse services ranging from discovery to drug substance...
PerkinElmer | 01-Jun-2021
| Technical / White Paper
The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...
The clinical development process for novel therapies that treat central nervous system (CNS) diseases is scientifically and medically complex, as demonstrated...
The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links & re-igniting discussions...
